Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

9.5%

2 terminated/withdrawn out of 21 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

43%

9 trials in Phase 3/4

Results Transparency

89%

16 of 18 completed trials have results

Key Signals

16 with results

Enrollment Performance

Analytics

Phase 2

10(47.6%)

Phase 3

9(42.9%)

Phase 1

1(4.8%)

N/A

1(4.8%)

21Total

Phase 2(10)

Phase 3(9)

Phase 1(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials

NCT04785638Phase 3Completed

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

Role: lead

NCT04785625Phase 3Completed

Efficacy and Safety Study of Postsurgical Analgesia With INL-001 in Abdominoplasty

Role: lead

NCT00593567Phase 2Completed

Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With a Mild Infection of a Foot Ulcer

Role: lead

NCT00600483Phase 3Completed

Safety and Efficacy of an Antibiotic Implant in Cardiac Surgical Subjects at Higher Risk for Sternal Wound Infection

Role: lead

NCT00659646Phase 2Completed

The Safety and Efficacy of an Antibiotic Sponge in Diabetic Patients With Moderately Infected Foot Ulcers

Role: lead

NCT02447172Phase 3Completed

Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers

Role: lead

NCT00600925Phase 3Completed

A Study of an Antibiotic Implant in General Surgical Subjects at Higher Risk for Surgical Wound Infection

Role: lead

NCT02348541Not ApplicableCompleted

Usability of the CollaGUARD Adhesion Barrier Following Hysteroscopic Adhesiolysis

Role: lead

NCT02427802Phase 3Completed

Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers

Role: lead

NCT03234374Phase 1Completed

Pharmacokinetics, Relative Bioavailability and Safety of INL-001 Compared to Marcaine After Open Hernioplasty

Role: lead

NCT03262688Phase 3Unknown

Safety, Tolerability, PK, and Analgesic Effect of INL-001 in Children Following Open Inguinal Hernia Repair

Role: lead

NCT00624910Phase 2Completed

Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy

Role: lead

NCT01220024Phase 2Completed

Safety and Efficacy of CollaRx® Bupivacaine Implant in Men After Open Laparotomy Herniorrhaphy

Role: lead

NCT00626886Phase 2Completed

Efficacy, Safety and Pharmacokinetic Profile of a Collagen Bupivacaine Implant in Men After Open Mesh Herniorrhaphy

Role: lead

NCT02525133Phase 3Completed

Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty

Role: lead

NCT02523599Phase 3Completed

Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty

Role: lead

NCT00749749Phase 2Completed

Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal Hysterectomy

Role: lead

NCT01224145Phase 2Completed

Assess the Feasibility and Efficacy of the CollaRx® Bupivacaine Implant Laparoscopic Inguinal or Umbilical Herniorrhaphy

Role: lead

NCT00661466Phase 2Terminated

Efficacy and Safety of A Collagen Bupivacaine Implant in Patients After Gastrointestinal Surgery

Role: lead

NCT02232178Phase 2Completed

Pharmacokinetics, Relative Bioavailability and Safety of Xaracoll Implant

Role: lead